TR200101826T2 - Üç-fazlı ağızdan alınan gebelik önleyici ilaç - Google Patents

Üç-fazlı ağızdan alınan gebelik önleyici ilaç

Info

Publication number
TR200101826T2
TR200101826T2 TR2001/01826T TR200101826T TR200101826T2 TR 200101826 T2 TR200101826 T2 TR 200101826T2 TR 2001/01826 T TR2001/01826 T TR 2001/01826T TR 200101826 T TR200101826 T TR 200101826T TR 200101826 T2 TR200101826 T2 TR 200101826T2
Authority
TR
Turkey
Prior art keywords
estrogen
progestogen
days
norethindrone
oral contraceptive
Prior art date
Application number
TR2001/01826T
Other languages
English (en)
Inventor
Shangold Gary
Rubin Arkady
Upmalis David
Original Assignee
Ortho-Mcnell Pharmaceutical,Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22349144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200101826(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho-Mcnell Pharmaceutical,Inc. filed Critical Ortho-Mcnell Pharmaceutical,Inc.
Publication of TR200101826T2 publication Critical patent/TR200101826T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bir estrojen ve bir progestojenin 21 gün için üç fazli bir sirada günlük sekilde tatbik edildigi bir gebelik önleme yöntemi anlatilmistir. Birinci fazda, progestojenik etkinlik olarak 0.065-0.75 noretindrona ve estrojenik etkinlik olarak 23-28 17a-etinilstradiole karsi gelen düsük fakat gebelik önlemede etkili günlük dozajda bir estrojen ve bir progestojen kombinasyonu; sonra, 7-11 gün için,progestojenik etkinlik olarak 0.25-1.0 mg noretindrona karsi gelen bir progestojen ve ayni dozajda estrojen; sonra, 3-7 gün için, progestojenik etkinlik olarak 0.35-2.0 mg noretindrona karsi gelen bir progestojen ve ayni dozajda estrojen tatbik edilerek; sonra,4-8 gün için, bir estrojen ya da bir progestojen tatbik edilmeden bir rejim uygulanmaktadir.
TR2001/01826T 1998-12-23 1999-12-08 Üç-fazlı ağızdan alınan gebelik önleyici ilaç TR200101826T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11339498P 1998-12-23 1998-12-23

Publications (1)

Publication Number Publication Date
TR200101826T2 true TR200101826T2 (tr) 2001-12-21

Family

ID=22349144

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01826T TR200101826T2 (tr) 1998-12-23 1999-12-08 Üç-fazlı ağızdan alınan gebelik önleyici ilaç

Country Status (26)

Country Link
US (2) US6214815B1 (tr)
EP (1) EP1140109B1 (tr)
JP (1) JP2002533398A (tr)
KR (1) KR100669165B1 (tr)
CN (1) CN100408040C (tr)
AR (1) AR028809A1 (tr)
AT (1) ATE318605T1 (tr)
AU (1) AU765153B2 (tr)
BR (1) BR9916579A (tr)
CA (1) CA2356747C (tr)
CY (1) CY1105276T1 (tr)
CZ (1) CZ302568B6 (tr)
DE (1) DE69930157T2 (tr)
DK (1) DK1140109T3 (tr)
ES (1) ES2259481T3 (tr)
HU (1) HU229251B1 (tr)
MX (1) MXPA01006533A (tr)
NO (1) NO321118B1 (tr)
NZ (1) NZ512404A (tr)
PL (1) PL196715B1 (tr)
PT (1) PT1140109E (tr)
RU (1) RU2225207C2 (tr)
SK (1) SK287931B6 (tr)
TR (1) TR200101826T2 (tr)
WO (1) WO2000038691A1 (tr)
ZA (1) ZA200106006B (tr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
HUP9900213A1 (hu) * 1999-02-01 2000-12-28 Gábor Bogye Gyógykompozíció(k) gesztagén tipusú hormon tartalmú gyógyszerek thromb-embóliás mellékhatásainak mérséklésére
US20060281723A1 (en) * 1999-04-16 2006-12-14 Kafrissen Michael E Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
US8048869B2 (en) * 2001-05-18 2011-11-01 Pantarhei Bioscience B.V. Pharmaceutical composition for use in hormone replacement therapy
EP1260225A1 (en) * 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
US20040202713A1 (en) * 2001-05-23 2004-10-14 Van Beek Agatha Antonia Magdalena Means and method for hormonal contraception
CA2448273C (en) * 2001-05-23 2010-06-29 Christian Franz Holinka Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
EP1390042B1 (en) * 2001-05-23 2007-11-28 Pantarhei Bioscience B.V. Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
DK1446128T3 (da) * 2001-11-15 2007-04-02 Pantarhei Bioscience Bv Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling
SI1453521T1 (sl) * 2001-12-05 2013-11-29 Teva Women's Health, Inc. Oralni kontraceptiki za preprečevanje nosečnosti in zmanjševanje predmenstrualne simptomatike
PT1511496E (pt) * 2002-06-11 2007-01-31 Pantarhei Bioscience Bv Método para tratamento ou prevenção de doenças mediadas pelo sistema imunitário e formulação farmacológica para utilização nas mesmas
US7943604B2 (en) * 2002-06-11 2011-05-17 Pantarhei Bioscience B.V. Method of treating human skin and a skin care composition for use in such a method
DK1526856T3 (da) 2002-07-12 2008-03-10 Pantarhei Bioscience Bv Farmaceutisk sammensætning omfattende estetrolderivater til anvendelse i cancerterapi
JP2004140323A (ja) * 2002-08-20 2004-05-13 Sharp Corp 半導体レーザ装置およびその製造方法
DK1556058T3 (da) * 2002-10-23 2008-03-03 Pantarhei Bioscience Bv Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi
EP1624848A4 (en) 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
KR20060129175A (ko) * 2003-10-01 2006-12-15 얀센 파마슈티카 엔.브이. 확장된 3상 피임 요법
DE102004026671A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
MX2007004120A (es) * 2004-10-07 2007-06-15 Duramed Pharmaceuticals Inc Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente.
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
EP2114412B1 (en) * 2007-01-08 2010-07-14 Pantarhei Bioscience B.V. Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
DE102007011486A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Arzneimittel umfassend wenigstens ein Gestagen
US20100178323A1 (en) 2007-07-10 2010-07-15 Agis Kydonieus Dermal Delivery Device
WO2010042610A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
EP2343963B1 (en) 2008-10-08 2019-04-10 Agile Therapeutics, Inc. Transdermal delivery
CA2740005C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
CA2756222A1 (en) 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
EP3310359A4 (en) 2015-06-22 2019-04-03 Lipocine Inc. ORAL COMPOSITIONS CONTAINING 17-HYDROXYPROGESTERONE ESTER AND METHODS RELATING THERETO

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3568828A (en) 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
US3836651A (en) 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
US3969502A (en) 1972-04-14 1976-07-13 Schering Aktiengesellschaft Method for contraception by the administration of sequential contraceptive preparations
DE2310963A1 (de) 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
US3932635A (en) 1972-04-24 1976-01-13 Syntex Corporation Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens
DE2365103C3 (de) 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4291028A (en) 1977-12-30 1981-09-22 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
NL8001593A (nl) 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
USRE35724E (en) 1982-04-28 1998-02-03 Bio-Technology General Corp. Contraception system and method
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4530839A (en) 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4544554A (en) 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4962098A (en) 1987-06-15 1990-10-09 Warner-Lambert Company Graduated estrogen contraceptive
US5023084A (en) 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US4948593A (en) 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5453279A (en) 1992-04-21 1995-09-26 Tbs Laboratories, Inc. Enhancing transdermal absorption compositions; transdermal dosage form; and process
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US5747480A (en) 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
US6214815B1 (en) 2001-04-10
US20010044429A1 (en) 2001-11-22
CA2356747A1 (en) 2000-07-06
AR028809A1 (es) 2003-05-28
WO2000038691A1 (en) 2000-07-06
SK8872001A3 (en) 2002-03-05
SK287931B6 (sk) 2012-04-03
HUP0104680A3 (en) 2002-06-28
EP1140109B1 (en) 2006-03-01
DE69930157T2 (de) 2006-08-31
CN1334734A (zh) 2002-02-06
NO20013144L (no) 2001-08-23
ATE318605T1 (de) 2006-03-15
ES2259481T3 (es) 2006-10-01
AU1936500A (en) 2000-07-31
MXPA01006533A (es) 2002-06-04
AU765153B2 (en) 2003-09-11
NO321118B1 (no) 2006-03-20
CZ302568B6 (cs) 2011-07-13
PL196715B1 (pl) 2008-01-31
KR20010081087A (ko) 2001-08-25
EP1140109A1 (en) 2001-10-10
CA2356747C (en) 2005-09-27
PT1140109E (pt) 2006-05-31
CY1105276T1 (el) 2010-03-03
NO20013144D0 (no) 2001-06-22
KR100669165B1 (ko) 2007-01-17
CN100408040C (zh) 2008-08-06
CZ20012184A3 (cs) 2003-01-15
BR9916579A (pt) 2001-10-02
HUP0104680A2 (hu) 2002-04-29
RU2225207C2 (ru) 2004-03-10
HU229251B1 (en) 2013-10-28
DK1140109T3 (da) 2006-05-15
DE69930157D1 (de) 2006-04-27
NZ512404A (en) 2003-08-29
ZA200106006B (en) 2002-10-21
JP2002533398A (ja) 2002-10-08

Similar Documents

Publication Publication Date Title
TR200101826T2 (tr) Üç-fazlı ağızdan alınan gebelik önleyici ilaç
NO914900D0 (no) Orale lav-estrogen-kontraseptiver
NO179311C (no) Flerfasekombinasjons- og kontraseptiv pakke
CA2018818A1 (en) Treatment of postmenopausal disorders
MX2008011074A (es) Metodo anticonceptivo oral multifasico de ciclo prolongado.
RU96119803A (ru) Комбинированный препарат для контрацепции на базе природных эстрогенов
EP0136011A3 (en) A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
DE69804918D1 (de) Sehr niedrigdosiertes orales Kontrazeptiv mit weniger Menstruationsblutungen und verzögerter Wirkung
ATE271386T1 (de) Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
CA2542854A1 (en) Graduated estrogen contraceptive
WO1998004246A3 (en) Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
NZ334876A (en) Hormonal composition consisting of an estrogenic derivative and a progestative agent
DE69731092D1 (de) Orales contrazeptivum
HUP9900612A2 (hu) Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra
ATE249222T1 (de) Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten